NRIX — Nurix Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Nurix Therapeutics, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

	2019 November 30th	2020 November 30th	2021 November 30th	2022 November 30th	2023 November 30th
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	37.5	281	295	309	288
Net Total Accounts Receivable
Net Total Receivables	—	11.3	6.2	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	39.4	298	311	318	296
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.87	6.67	25.3	29.5	48
Long Term Investments
Other Long Term Assets
Total Assets	44	396	477	417	356
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	16.1	44.5	66.3	70.7	87
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	53.6	106	134	113	155
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-9.52	290	342	304	200
Total Liabilities & Shareholders' Equity	44	396	477	417	356
Total Common Shares Outstanding